As we continue to face a worldwide public health crisis, the Reagan-Udall Foundation is your connection to the latest, science-based information regarding COVID-19 and the products we use, the food we eat, and the medicine we take.
The COVID-19 Evidence Accelerator, in collaboration with Friends of Cancer Research, is leveraging real-world evidence to support FDA’s response to the global pandemic.
Navigating Medical & Treatment Developments for COVID-19
The COVID-19 Treatment Hub provides physicians, patients, and caregivers with information about the latest research in the fight against COVID-19. Many companies are currently developing new therapies and vaccines for coronavirus and/or evaluating how drugs that are currently available may treat the symptoms of COVID-19.
While there are no drugs, therapeutics, or vaccines yet approved to specifically treat, cure, or prevent COVID-19, there are options —from enrolling in clinical trials to requesting access to investigational products being tested by biopharmaceutical companies.
Clinical trials are necessary to gain regulatory approvals so new treatments are broadly available to patients as quickly as possible. Expanded access, which can provide access to investigational therapies when a patient does not qualify for a clinical trial, is sometimes available as well but must not interfere with clinical trials as it could delay availability of the approved treatment to the wider public. You can learn more about expanded access in our Expanded Access Navigator, which features guides for patients and caregivers, healthcare providers, and companies.
Click below to locate companies conducting COVID-19 research, learn about new and existing clinical trials, identify expanded access opportunities, and find trusted resources to guide you through this pandemic.